...
首页> 外文期刊>The Journal of hospital infection >Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK
【24h】

Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK

机译:英国大学教学医院成人住院治疗成人住院治疗肠蛋白酶肠杆菌肠杆菌和万古霉素耐药肠杆菌的患病率调查

获取原文
获取原文并翻译 | 示例
           

摘要

Infections with carbapenemase-producing Enterobacteriaceae (CPE) and vancomycin-resistant enterococci (VRE) are associated with increased morbidity and mortality, but the carriage rates of CRE and VRE among hospital inpatients are unknown. A point-prevalence survey was conducted to determine CPE and VRE carriage rates in hospitalized adults. Eight hundred and eighteen of 960 (85.2%) adult inpatients were invited to participate in the study. Of these, 595 patients (72.7%) consented and provided specimens. Of 540 samples tested, none were positive for CPE. One hundred and thirty of 540 (24.1%) samples were VRE positive, and 34 of 40 (85%) of wards had cases. Universal screening for CPE may not be cost-effective in low-prevalence settings, but targeted screening of high-risk patients should continue. The optimal screening strategy for VRE remains to be determined, as universal screening and isolation is not feasible in the study setting.
机译:产生碳结氨酸酶的肠杆菌(CPE)和万古霉素抗性肠球菌(VRE)的感染与发病率和死亡率增加有关,但CRE和医院住院患者中的VRE的运输率未知。 进行了普遍存在的调查,以确定住院成人的CPE和VRE托架率。 邀请八百八十六十八(85.2%)成年住院患者参加该研究。 其中595名患者(72.7%)同意和提供标本。 在540个样品中测试,NONE是CPE的阳性。 540(24.1%)样品中的一百三十次是阳性的,40个(85%)病房有34个病例。 对CPE的通用筛查可能在低流行设置中不具有成本效益,但有针对性的高危患者的筛查应该继续。 VRE的最佳筛选策略仍有待确定的,因为在研究环境中,通用筛选和隔离是不可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号